Fig. 6From: 3,4-diaminopyridine treatment for Lambert-Eaton myasthenic syndrome in adults: a meta-analysis of randomized controlled trialsFunnel plot for within study CMAP differences between 3,4-diaminopyridine treatment and placebo groups for each trialBack to article page